摘要:
The invention relates to novel heterocyclic acrylamide compounds (I), to the preparation of the compounds and intermediates used therein, to the use of the compounds as antibacterial medicaments and pharmaceutical compositions containing the compounds.
摘要:
The invention relates to a novel hydroxyphenyl compound, to the preparation of the compound and intermediates used therein, to the use of the compound as an antibacterial medicament and pharmaceutical compositions containing the compound.
摘要:
A subject of the invention is a process for the preparation of the compounds of formula (I): Wherein the substituents are defined as in the application. The compounds of this invention exhibit antibiotic properties.
摘要:
A compound of the formula wherein X=CH2 or NH, Y=H or Hal, Z=H or acyl of an organic carboxylic acid of 1 to 6 carbon atoms, R is W and W′ are individually H, Hal and alkyl of 1 to 8 carbon atoms optionally substituted by at least one halogen having antibiotic properties.
摘要:
Compounds of the formula ##STR1## wherein X and X' form C.dbd.O or C.dbd.NOR, R is selected from the group consisting of hydrogen, heterocycle, alkyl, alkenyl, alkynyl, all optionally substituted, ##STR2## R.sub.a and R.sub.b are hydrogen or a hydrocarbon group or form together with the nitrogen a heterocycle, or with A forms a 9-N, 11-O ring, and X' is hydrogen, --Y and Y' have the same definition as X and X', b is hydrogen or OR.sub.4, R.sub.4 is hydrogen or forms together with A a carbonate or a carbamate, A forms with C a double bond or A is OR'.sub.4, R'.sub.4 is hydrogen or forms together with B a carbonate or ##STR3## R.sub.2 is alkyl or --CONH.sub.2, --CONHCOR.sub.11 or --CONHSO.sub.2 R.sub.11, R.sub.11 is a hydrocarbon up to 18 carbon atoms, R.sub.3 is hydrogen, ##STR4## and Z is hydrogen or a carboxylic acid remainder and their non-toxic, pharmaceutically acceptable acid addition salts, their preparation and intermediates useful as antibiotics.
摘要翻译:式I的化合物其中X和X'形成C = O或C = NOR,R选自氢,杂环,烷基,烯基,炔基,全部被取代,R a和R b 是氢或烃基或与氮杂环的形式,或与A一起形成9-N,11-O环,X'为氢,-Y和Y'具有与X和X'相同的定义, b是氢或OR 4,R 4是氢或与A一起形成碳酸酯或氨基甲酸酯,A形式与C是双键或A是OR'4,R'4是氢或与B一起形成碳酸酯或 R 2是烷基或-CONH 2,-CONHCOR 11或-CONHSO 2 R 11,R 11是至多18个碳原子的烃,R 3是氢,Z是氢或羧酸残基及其无毒的药学上可接受的酸加成盐 ,它们的制备和中间体可用作抗生素。
摘要:
Compounds of the formula ##STR1## wherein X and X' form C.dbd.O or C.dbd.NOR, R is selected from the group consisting of hydrogen, heterocycle, alkyl, alkenyl, alkynyl, all optionally substituted, or X is ##STR2## R.sub.a and R.sub.b are hydrogen or a hydrocarbon group or form together with the nitrogen a heterocycle, or with A forms a 9-N, 11-0 ring, and X' is hydrogen, --Y and Y' have the same definition as X and X', B is hydrogen or OR.sub.4, R.sub.4 is hydrogen or forms together with A a carbonate or a carbamate, A forms with C a double bond or A is OR'.sub.4, R'.sub.4 is hydrogen or forms together with B a carbonate or A is ##STR3## R.sub.2 is alkyl or --CONH.sub.2, --CONHCOR.sub.11 or --CONHSO.sub.2 R.sub.11, R.sub.11 is a hydrocarbon up to 18 carbon atoms, R.sub.3 is hydrogen, ##STR4## and Z is hydrogen or a carboxylic acid remainder and their non-toxic, pharmaceutically acceptable acid addition salts, their preparation and intermediates useful as antibiotics.
摘要:
The invention relates to Imidazolo-heteroaryl derivatives of formula (I). The compounds inhibit the activity of the Dlta enzyme of Gram-positive bacteria and are useful to treat Gram-positive bacterial infections. Furthermore the application discloses method for assessing the Dlta inhibitory activity of tested molecules and a method for measuring the efficacy of molecules in inhibiting bacteria proliferation in vitro.
摘要:
The invention relates to new compounds having heptose synthesis inhibitory properties, of formula (I) or a pharmaceutically acceptable salt, or prodrug thereof, wherein A is an aryl or heterocycle, optionally substituted by one or several identical or different R such as H, C1-C10 alkyl, C1-C10 alkyl-OR1, C1-C10 alkyl-NR1R1, alkoxy, hydroxy, thioalkyl, aryl, heterocycle, halogen, nitro, cyano, CO2R1, NR1R1, NR1C(O)R1, C(O)NR1R1, NR1C(S)R1, C(S)NR1R1, SO2NR1R1, SO2R1, NR1SO2R1, NR1C(O)NR1R1, NR1C(O)OR1, NR1C(S)NR1R1, NR1C(S)OR1, R1C═NOR1, C(O)R1, aryloxy, thioaryl, alkenyl, alkynyl R1 identical or different is H or C1-C10 alkyl B1, B2, B3 identical or not represent C, N, O, S to form a five-membered aromatic ring wherein from one to three carbon atoms are replaced by a heteroatom selected from S, O, N optionally substituted by one or several identical or different R such as defined above B4 is C or N Y is H, C1-C10 alkyl, alkoxy, thio-alkyl, optionally substituted by one or several identical or different R such as defined above W is C, O or N, substituted or not by one or several C1-C10 alkyl radicals D is an heterocycle optionally substituted by one or several identical or different R such as defined above.
摘要翻译:本发明涉及具有式(I)的肝素合成抑制性质的新化合物或其药学上可接受的盐或前药,其中A是芳基或杂环,任选被一个或多个相同或不同的R如H,C1 C 1 -C 10烷基-OR 1,C 1 -C 10烷基-NR 1 R 1,烷氧基,羟基,硫代烷基,芳基,杂环,卤素,硝基,氰基,CO 2 R 1,NR 1 R 1,NR 1 C(O)R 1,C(O)NR 1 R 1, NR 1 C(S)R 1,C(S)NR 1 R 1,SO 2 NR 1 R 1,SO 2 R 1,NR 1 SO 2 R 1,NR 1 C(O)NR 1 R 1,NR 1 C(O)OR 1,NR 1 C R1,芳氧基,硫代芳基,烯基,炔基R1相同或不同,是H或C1-C10烷基B1,B2,B3相同或不表示C,N,O,S,形成五元芳环,其中一至三碳 原子被选自S,O,N的杂原子替代,任选地被一个或多个相同或不同的R取代,如上定义。B4是C或NY是H,C1-C10烷基,烷氧基,硫代烷基,任选被一个 或几个iden 如W所定义的不同的R是C,O或N,被一个或多个C 1 -C 10烷基取代或不被取代,D是任选被一个或多个相同或不同的R如上所定义的R取代的杂环。